Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Rice

Showing results (181-190 of 238) with videos related to

Pageof 24
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 1, 2020
Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapyErin M Corsini, Annikka Weissferdt, Apar Pataer, et al.
The Annals of Thoracic Surgery|August 29, 2020
Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant ChemoradiationErin M Corsini, Kyle G Mitchell, Nicolas Zhou, et al.
The Annals of Thoracic Surgery|May 10, 2021
Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural MesotheliomaNicolas Zhou, David C Rice, Anne S Tsao, et al.
The Annals of Thoracic Surgery|March 14, 2018
Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung CancerRobert M Van Haren, Reza J Mehran, Gabriel E Mena, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 9, 2005
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implicationsJeremy J Erasmus, Mylene T Truong, W Roy Smythe, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 26, 2023
Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategyNathaniel Deboever, Erin M Bayley, Michael A Eisenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural MesotheliomaAndreas Rimner, Marjorie G Zauderer, Daniel R Gomez, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 8, 2009
Impact of tumor length on long-term survival of pT1 esophageal adenocarcinomaWilliam D Bolton, Wayne L Hofstetter, Ashleigh M Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategiesKazuki Sudo, Takashi Taketa, Arlene M Correa, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 7, 2017
Predictors of trimodality therapy and trends in therapy for malignant pleural mesotheliomaDavid B Nelson, David C Rice, Jiangong Niu, et al.
Pageof 24

Showing results (181-190 of 238) with videos related to

Sort By:
Pageof 24
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 1, 2020
Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapyErin M Corsini, Annikka Weissferdt, Apar Pataer, et al.
The Annals of Thoracic Surgery|August 29, 2020
Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant ChemoradiationErin M Corsini, Kyle G Mitchell, Nicolas Zhou, et al.
The Annals of Thoracic Surgery|May 10, 2021
Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural MesotheliomaNicolas Zhou, David C Rice, Anne S Tsao, et al.
The Annals of Thoracic Surgery|March 14, 2018
Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung CancerRobert M Van Haren, Reza J Mehran, Gabriel E Mena, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 9, 2005
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implicationsJeremy J Erasmus, Mylene T Truong, W Roy Smythe, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 26, 2023
Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategyNathaniel Deboever, Erin M Bayley, Michael A Eisenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural MesotheliomaAndreas Rimner, Marjorie G Zauderer, Daniel R Gomez, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 8, 2009
Impact of tumor length on long-term survival of pT1 esophageal adenocarcinomaWilliam D Bolton, Wayne L Hofstetter, Ashleigh M Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategiesKazuki Sudo, Takashi Taketa, Arlene M Correa, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 7, 2017
Predictors of trimodality therapy and trends in therapy for malignant pleural mesotheliomaDavid B Nelson, David C Rice, Jiangong Niu, et al.
Pageof 24